Abiopharma

🔍 WHITE BRETT T (Director)

Company: Weave Communications, Inc. (WEAV)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Acquired 600,000 shares of Common Stock (Direct)
  Date: 2026-04-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,354,742.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 600,000 shares of Common Stock (Direct)
  Date: 2026-04-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,954,742.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 33% of the total number of shares on March 1, 2027, and the remainder in equal quarterly installments over the two years thereafter, until such time as the RSU is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
• F2: Performance-based PSUs vest in three equal tranches upon certification that the 30-day average stock price milestones of $7.00, $9.00, and $11.00 are achieved on or after March 1, 2026, and on or before April 1, 2027, September 1, 2027, and March 1, 2028, respectively, subject to continued service and the following time-based vesting conditions. Unmet tranches are forfeited; achievement of a higher milestone also satisfies any lower outstanding milestones. Upon milestone achievement, each tranche vests based on service: 33% on March 1, 2027 and the remainder in quarterly installments over the two years thereafter, until such time as the RSU is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.